265 related articles for article (PubMed ID: 30902899)
21. Targeting interleukin-22 in psoriasis.
Hao JQ
Inflammation; 2014 Feb; 37(1):94-9. PubMed ID: 23978911
[TBL] [Abstract][Full Text] [Related]
22. Involvement of IL-17F via the induction of IL-6 in psoriasis.
Fujishima S; Watanabe H; Kawaguchi M; Suzuki T; Matsukura S; Homma T; Howell BG; Hizawa N; Mitsuya T; Huang SK; Iijima M
Arch Dermatol Res; 2010 Sep; 302(7):499-505. PubMed ID: 20148256
[TBL] [Abstract][Full Text] [Related]
23. Mechanical Stretch Exacerbates Psoriasis by Stimulating Keratinocyte Proliferation and Cytokine Production.
Qiao P; Guo W; Ke Y; Fang H; Zhuang Y; Jiang M; Zhang J; Shen S; Qiao H; Dang E; Wang G
J Invest Dermatol; 2019 Jul; 139(7):1470-1479. PubMed ID: 30641039
[TBL] [Abstract][Full Text] [Related]
24. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
[TBL] [Abstract][Full Text] [Related]
25. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
[TBL] [Abstract][Full Text] [Related]
26. PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis.
Mercurio L; Morelli M; Scarponi C; Scaglione GL; Pallotta S; Albanesi C; Madonna S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685616
[TBL] [Abstract][Full Text] [Related]
27. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
[TBL] [Abstract][Full Text] [Related]
28. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
29. [A mathematical model of paracrine regulation of the proliferative activity of epidermis with the participation of T-lymphocytes].
Laptev MV; Nikulin NK
Biofizika; 2010; 55(2):361-74. PubMed ID: 20429294
[TBL] [Abstract][Full Text] [Related]
30. Curcumin alleviates imiquimod-induced psoriasis in progranulin-knockout mice.
Zhou T; Zhang S; Zhou Y; Lai S; Chen Y; Geng Y; Wang J
Eur J Pharmacol; 2021 Oct; 909():174431. PubMed ID: 34428436
[TBL] [Abstract][Full Text] [Related]
31. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
[TBL] [Abstract][Full Text] [Related]
32. Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β.
Chen JQ; Man XY; Li W; Zhou J; Landeck L; Cai SQ; Zheng M
Cell Biochem Biophys; 2013 Jul; 66(3):523-8. PubMed ID: 23283814
[TBL] [Abstract][Full Text] [Related]
33. Proinflammatory effect of high-mobility group protein B1 on keratinocytes: an autocrine mechanism underlying psoriasis development.
Zhang W; Guo S; Li B; Liu L; Ge R; Cao T; Wang H; Gao T; Wang G; Li C
J Pathol; 2017 Feb; 241(3):392-404. PubMed ID: 27859256
[TBL] [Abstract][Full Text] [Related]
34. MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation.
Monin L; Gudjonsson JE; Childs EE; Amatya N; Xing X; Verma AH; Coleman BM; Garg AV; Killeen M; Mathers A; Ward NL; Gaffen SL
J Immunol; 2017 Jan; 198(2):767-775. PubMed ID: 27920272
[TBL] [Abstract][Full Text] [Related]
35. Cyr61/CCN1 induces CCL20 production by keratinocyte via activating p38 and JNK/AP-1 pathway in psoriasis.
Li H; Li H; Huo R; Wu P; Shen Z; Xu H; Shen B; Li N
J Dermatol Sci; 2017 Oct; 88(1):46-56. PubMed ID: 28602508
[TBL] [Abstract][Full Text] [Related]
36. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
37. TNF-α and IL-17A induce the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
Sugihara S; Sugimoto S; Tachibana K; Kobashi M; Nomura H; Miyake T; Hirai Y; Yamasaki O; Morizane S
J Dermatol Sci; 2019 Oct; 96(1):26-32. PubMed ID: 31501002
[TBL] [Abstract][Full Text] [Related]
38. Sprouty1 exerts a preventive effect on the initiation of psoriasis by inhibiting innate immune antimicrobial peptide cathelicidin and immunocytes.
Zhou Y; Wang P; Chen XY; Yan BX; Landeck L; Wang ZY; Xu F; Zheng M; Man XY
Cell Prolif; 2022 Oct; 55(10):e13290. PubMed ID: 35716036
[TBL] [Abstract][Full Text] [Related]
39. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
40. Keratinocyte proline-rich protein modulates immune and epidermal response in imiquimod-induced psoriatic skin inflammation.
Matsuno A; Sumida H; Nakanishi H; Ikeyama Y; Ishii T; Omori I; Saito H; Iwasawa O; Sugimori A; Yoshizaki A; Katoh H; Ishikawa S; Sato S
Exp Dermatol; 2023 Dec; 32(12):2121-2130. PubMed ID: 37926955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
